Turn this list into pipeline.
Pharmaceuticals Companies in Manchester: 400+ Active Firms (2026)
Pharmaceuticals companies in Manchester research, manufacture, license and distribute regulated medicines across the city region.
Buying centres tend to sit in quality, regulatory affairs, supply chain, commercial access and clinical operations rather than in a single technology budget. The customer base is mainly institutional: public healthcare access teams, hospital and community pharmacy channels, wholesalers, contract manufacturing partners, trial sponsors and export buyers. Sales cycles are therefore shaped by validation, licence status, batch assurance, pharmacovigilance cover and evidence of dependable supply. Engagements tend to be operationally material rather than transactional, with procurement, technical assessment and audit work preceding recurring manufacturing, distribution or commercialisation relationships. Smaller specialists can still fit where they hold a narrow formulation, import, licensing or quality role inside a wider medicines supply chain.
Read more
Manchester has 445 actively trading pharmaceuticals companies in this list, a city-region cohort with a small revenue-scaled tail and a large recent-incorporation layer. 17 firms report turnover above £5M, while 200 were incorporated since 2022, so the market mixes established licence holders and distributors with younger entrants around formulation, import, wholesale and services. The employment footprint is more modest than the company count suggests: reported headcount totals 469, with 82 firms recording staff numbers. That points to a market where many entities remain owner-managed, asset-light or licence-led, alongside a smaller group carrying manufacturing, quality, warehouse and commercial teams.
Human medicines activity is anchored by MHRA licensing rather than ordinary wholesale or research rules. Manufacturers, assemblers and importers need a manufacturer’s licence, must comply with good manufacturing practice and are subject to site inspection. Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance. Medicines need marketing authorisation before commercial sale, and post-market pharmacovigilance remains part of the operating model. ABPI frames the regulator’s remit as standards-setting, treatment evaluation, clinical-trial approval, medicines licensing and safety monitoring, which is why even smaller Manchester operators tend to carry regulatory affairs and quality assurance capacity.
The Manchester cohort appears likely to polarise between licence-led specialists and operators with the infrastructure to support manufacturing, import, distribution and market access work. Quality systems, pharmacovigilance and inspection readiness tend to raise the cost of scaling, which may keep many firms at specialist or project-based scale for longer. Consolidation is plausible where warehouse capability, authorisations or public healthcare routes are costly to duplicate. Younger entrants may also find that commercial progress depends less on discovery claims than on evidence, audit history and the ability to keep regulated supply moving without interruption.
445
Active firms
2026
17
Above £5M revenue
Manchester cohort
200
Incorporated since 2022
Newer registrations
Key facts
About 3% of the trading cohort reports turnover above £5M (17 of 445 firms) — the rest sits below that revenue band.
44% of the cohort was incorporated since 2022 (200 firms), so a sizeable share is in its first few filing cycles.
Human medicines in the UK fall under MHRA oversight, covering standards, clinical-trial approvals, licensing and pharmacovigilance.
Manufacturers, assemblers and importers of human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
Pharmaceutical businesses performed £9.0 billion of R&D in the UK business enterprise sector in 2022, equal to 0.36% of UK GDP.
UK pharmaceutical exports were valued at £25.6 billion in 2023, with the UK ranked tenth among comparator countries for this metric.
Top Manchester pharmaceuticals companies
Develops and licenses paediatric medicines designed for children, focusing on treatments in neurology and cardiology. Conducts research and development and works with clinicians and caregivers to…
Serves healthcare professionals and healthcare organisations treating paediatric patients, alongside patients, parents and carers seeking medicine information. Focuses on children with chronic…
Financial Health
Insufficient historyInsufficient history
Location
Mobius Health Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract microbiological and sterility testing for pharmaceutical products. Offers pharmaceutical product development, regulatory support, manufacturing, batch testing and certification, and…
Serves B2B customers in the pharmaceutical, nutraceutical and medical supplies sectors, including product licence holders, manufacturers, wholesalers and companies operating in UK and export markets.
Financial Health
HealthyHealthy · Growing · 0% CAGR over 2y
Location
PANMEDISO INVESTMENTS LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and supplies medical isotopes and radiopharmaceutical technologies for nuclear medicine. Conducts isotope R&D and production, radiopharmaceutical assembly, and contract manufacturing (CDMO),…
Serves B2B healthcare and life sciences buyers, including radiopharmaceutical manufacturers, hospitals, nuclear medicine clinicians, and research organisations involved in precision diagnostics and…
Financial Health
StableStable
Location
PRESTWICH PHARMACY LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsOperates a community pharmacy providing NHS and private prescription dispensing, minor ailment treatment, and health consultations. Offers services including travel vaccinations, flu and COVID…
Serves local residents and patients in Prestwich, including NHS and private prescription users, families and travellers, plus employers arranging workplace or occupational vaccinations for staff.
Financial Health
WeakWeak · 3% CAGR over 2y
Location
Develops small‑molecule drug candidates for immuno‑inflammatory diseases. Uses proprietary molecular design and patient stratification platforms to identify and optimise targets, advancing discovery…
Targets global pharmaceutical and biotechnology partners, such as large pharma licensing teams, in immuno-inflammation and related therapeutic areas; also communicates with shareholders and life…
Location
SIGMA BIOTICS LTD
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
RHAZES PHARMA LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
WeakWeak · 0% CAGR over 1y
Location
Zydex Healthcare Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFacilitates the international supply of pharmaceutical products, sourcing and brokering medicines, medical products, equipment and consumables. Provides import and export services and procurement…
Serves healthcare-sector businesses and related industries in the UK and internationally, including buyers sourcing pharmaceutical supplies, medical products, equipment and consumables.
Financial Health
WeakWeak
Location
AK SONS TRADING LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsOperates community pharmacies providing prescription dispensing, medicines supply, and healthcare advice. Also delivers dedicated pharmacy services to care homes, including medication management and…
Serves individual pharmacy patients, local community members and care homes, with a focus on customers in the North West and Stoke-on-Trent area.
Financial Health
HealthyHealthy · Hiring · 6% CAGR over 4y
Location
TAYYIB NATURALS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides GMP-compliant contract analytical laboratory services for pharmaceutical and healthcare products, including QC batch release testing, pharmacopoeial analysis, chemical and physical testing,…
Serves pharmaceutical and healthcare companies outsourcing GMP analytical work, including R&D, quality control, supply-chain and compliance teams handling finished products, raw materials and…
Financial Health
DistressedDistressed · 0% CAGR over 4y
Location
Discovers and develops small‑molecule drug candidates for immuno‑inflammatory diseases. Uses proprietary molecular design and patient stratification platforms to identify targets and advance…
Serves pharmaceutical and biotech companies through drug discovery partnerships, particularly in immuno-inflammatory medicine development. Also targets investors and shareholders through its…
Location
EVERSANA UK LIMITED
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsProvides commercial services to pharmaceutical and life sciences companies, including market access and pricing strategy, regulatory and medical affairs support, patient access and adherence…
Serves B2B life sciences companies, including pharmaceutical and biotech firms commercialising therapies, with emphasis on product launch, market access, patient support, pricing, regulatory, medical…
Financial Health
StrongStrong · Growing, Hiring · 46% CAGR over 1y
Location
PROTEINTECH EUROPE LIMITED
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · -60% CAGR over 4y
Location
Enchanted Brave Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
ISCRIPT LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops small‑molecule drug candidates for immuno‑inflammatory diseases. Uses proprietary molecular design and patient stratification platforms to identify and optimise compounds, advancing…
Serves pharmaceutical and biotechnology companies, including large pharma partners, focused on immuno-inflammatory disease pipelines; also addresses investors and shareholders in life sciences.
Financial Health
DistressedDistressed
Location
Biosimax Lifesciences Ltd
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Mason Jones Services Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
StrongStrong
Location
HA PHARMA CONSULTANCY LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak
Location
LloydsPharmacy
Trajectory
1y · 2023–NowOperates an online pharmacy providing prescription dispensing, over‑the‑counter medicines, health diagnostics and personal care products. Sells medical devices, baby care items, vitamins and…
Serves UK consumers and patients, including families, parents, carers and people managing everyday health conditions, seeking pharmacy products, prescriptions, medicines, baby care, wellbeing and…
Financial Health
Insufficient historyInsufficient history
Location
LloydsPharmacy
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsOperates an online and in‑store pharmacy retailing prescription medicines, over‑the‑counter treatments, health products, medical devices, and personal care items. Provides prescription dispensing,…
Sells directly to UK consumers seeking online and in-store pharmacy services, prescriptions, medicines, health products and personal care items, including parents, people managing ongoing conditions,…
Financial Health
StrongStrong · Growing, Hiring · 960% CAGR over 2y
Location
SASH VITALITY LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
WeakWeak
Location
Mawdsleys
Provides pharmaceutical wholesale and distribution services to hospitals, healthcare providers, and pharmaceutical companies. Offers storage, logistics and fulfilment, temperature‑controlled…
Serves hospitals, healthcare providers, pharmaceutical and biotech companies, and healthcare-sector businesses worldwide, including secondary care and pharma teams responsible for medicine supply and…
Location
STOCKPORT HEALTHCARE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical “specials” and clinical trial medicines, including sterile, non-sterile and aseptic preparations. Supplies customised, non‑commercially available medicines for healthcare…
Serves healthcare professionals, NHS and healthcare organisations, and pharmaceutical customers needing non-commercially available specials, aseptic products, sterile and non-sterile preparations, or…
Financial Health
WeakWeak · -64% CAGR over 4y
Location
Cohens Chemist
Operates a pharmacy chain and online pharmacy platform providing NHS and private prescriptions, repeat prescription ordering, click‑and‑collect and home delivery. Offers pharmacist consultations,…
Serves UK consumers and NHS patients seeking repeat prescriptions, pharmacy-first treatment, vaccinations, contraception, weight-loss support, private prescriptions and GP-linked online services for…
Location
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsManufactures and supplies bespoke pharmaceutical ‘specials’ and unlicensed medicines made to order for pharmacies, dispensing doctors, hospitals and pharmaceutical wholesalers. Provides custom…
Serves UK dispensing doctors, community pharmacies, hospital and hospital pharmacy teams, and pharmaceutical wholesalers needing made-to-order medicines for patients.
Financial Health
HealthyHealthy · -77% CAGR over 3y
Location
SEDA PHARMA DEVELOPMENT SERVICES LTD.
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides pharmaceutical development and clinical pharmacology services for pharmaceutical and biotechnology companies, including formulation development, laboratory testing, pharmacokinetic…
Serves B2B pharmaceutical and biotechnology companies developing drug candidates, from early-stage programmes through clinical development and marketing authorisation.
Financial Health
HealthyHealthy · -62% CAGR over 4y
Location
SEDA CLINICAL MANUFACTURING SERVICES LTD.
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsProvides GMP manufacturing and testing services for pharmaceutical and biotechnology companies developing investigational medicinal products. Specialises in non‑sterile oral solid dosage forms,…
Serves pharmaceutical and biotech companies progressing drug candidates into and through clinical development, especially teams responsible for investigational medicinal products, quality control,…
Financial Health
WeakWeak · Hiring · 86% CAGR over 1y
Location
NORVO CHEMICALS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures pharmaceutical medicines for diabetes and other chronic diseases, including insulin and GLP‑1 based treatments. Conducts research, production and commercialisation of…
Serves patients with diabetes and other serious chronic diseases, alongside healthcare professionals and healthcare organisations involved in prescribing, managing or providing access to approved…
Financial Health
DistressedDistressed
Location
APOLLO PHARMA LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides contract development and manufacturing services to pharmaceutical and healthcare companies, acting as a CMDO partner for the development and production of pharmaceutical and healthcare…
Serves pharmaceutical and healthcare businesses, likely companies seeking outsourced development or manufacturing support from a CMDO partner.
Financial Health
StableStable · Hiring · 6% CAGR over 4y
Location
Mawdsleys
Provides pharmaceutical wholesale and distribution services, supplying medicines to hospitals and healthcare providers. Offers pharmaceutical storage, temperature‑controlled logistics, order…
Serves B2B customers in the pharmaceutical industry and healthcare sector, including hospitals, secondary care providers, healthcare professionals, pharmaceutical and biotech companies, and global…
Location
Cohens Chemist
Operates a chain of community pharmacies and an online pharmacy platform providing NHS and private prescription dispensing, repeat prescription ordering and tracking, click‑and‑collect medicines, GP…
Serves consumers and NHS patients, especially people managing repeat medication or seeking pharmacy consultations, vaccinations, contraception, weight-loss support and private prescriptions.
Location
Cohens Chemist
Operates community and online pharmacies providing NHS and private prescription dispensing, repeat prescription ordering, click‑and‑collect medicines, vaccinations, contraception supply, blood…
Serves UK consumers and NHS patients who need pharmacy services, repeat prescriptions, GP-linked online access, flu jabs, contraception, weight-loss support and private prescription fulfilment for…
Location
Cohens Chemist
Operates community and online pharmacy services dispensing NHS and private prescriptions. Provides repeat prescription ordering, click‑and‑collect and delivery, flu vaccinations, blood pressure…
Serves consumers and NHS patients seeking online and branch pharmacy access, including repeat-prescription users, people booking flu jabs or health checks, and private-prescription customers.
Location
Cohens Chemist
Operates retail and online pharmacy services providing NHS and private prescription dispensing, repeat prescription ordering, and medication delivery or collection. Also offers pharmacist…
Serves UK consumers and NHS patients needing community pharmacy services, repeat prescription support, GP-linked online access, private prescriptions, vaccinations and in-branch health services.
Location
Herd Mundy Richardson Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract analytical and pharmaceutical testing services for drug developers and manufacturers, including stability studies, inhaled and finished product testing, microbiological analysis,…
Serves pharmaceutical and healthcare companies developing or manufacturing drug products, including therapeutics, inhaled/nasal products, ingredients and finished medicines, that need independent…
Financial Health
StableStable · 0% CAGR over 2y
Location
RPH PHARMA LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · Profitable
Location
Cohens Chemist
Operates a pharmacy chain and online chemist platform providing NHS and private prescription dispensing, repeat prescription ordering and tracking, and click‑and‑collect. Offers services such as flu…
Serves UK consumers and NHS patients needing online or branch pharmacy access, including repeat prescription users, people seeking common-condition treatment, flu jabs, contraception, weight loss…
Location
Cohens Chemist
Operates a chain of pharmacies and an online pharmacy platform providing NHS and private prescription dispensing, repeat prescription ordering, click‑and‑collect and delivery, vaccinations,…
Sells primarily to UK consumers and NHS patients needing pharmacy, prescription and GP-linked health services, including repeat medication users, people seeking flu jabs, contraception, blood…
Location
Provides contract development and manufacturing services for advanced therapy products including gene therapies, vaccines and immunotherapies. Offers process development, formulation, analytics and…
Serves life-science innovators and advanced therapy developers, including biotech and pharma teams working on gene therapies, immunotherapies, oncolytics and vaccines from research through…
Location
MISTRY MEDICAL LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsSupplies pharmaceuticals, vaccines including influenza vaccines, and a wide range of medical equipment and consumables such as diagnostic devices, PPE, surgical instruments, and clinical furniture…
Serves healthcare organisations including GP surgeries, hospitals, NHS buyers and private medical establishments, plus specialist clinical settings such as dental, podiatry, physiotherapy, travel…
Financial Health
StableStable · 0% CAGR over 3y
Location
SCOPE INTERNATIONAL (UK) LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract research organisation services for pharmaceutical and biotechnology companies, managing clinical trials from Phase I–IV. Services include clinical operations, medical writing,…
Serves pharmaceutical, biotech and advanced therapy developers needing B2B clinical research partners for Phase I–IV studies, particularly in pain, women’s health, respiratory, neurology, infectious…
Financial Health
StrongStrong · Hiring · 18% CAGR over 2y
Location
Stratlab Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
LAMB'S LOCUM SERVICES LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · -13% CAGR over 5y
Location
Seemed Healthcare Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies medical and healthcare products, including medical devices, diagnostic equipment, life‑saving medicines, and clinical consumables. Offers products across categories such as diabetes care,…
Sells to healthcare providers and medical institutions, serving healthcare professionals, clinics, hospitals and other organisations needing medical devices, diagnostic equipment, medicines and…
Financial Health
WeakWeak · 1% CAGR over 4y
Location
Aesthipharma Limited
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
ID MEDICAL SUPPLY LTD
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · -21% CAGR over 3y
Location
Develops rare disease therapeutics by acquiring and advancing deprioritised drug candidates from pharmaceutical companies. Pipeline includes an antisense oligonucleotide for Angelman syndrome,…
Targets healthcare providers, hospitals and specialist clinics treating rare diseases, including Angelman syndrome, complications of extremely premature birth and diabetic macular edema; also engages…
Location
P & A J CATTEE (WHOLESALE) LTD.
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsSupplies and wholesales pharmaceutical products and operates community and online pharmacies. Dispenses NHS prescriptions and sells over‑the‑counter medicines and health products, and provides…
Serves UK consumers and patients using online and local community pharmacy services, including NHS prescription users and people booking pharmacy health services.
Financial Health
StrongStrong · Hiring · 10% CAGR over 4y
Location
PARBOLD THERAPEUTICS LIMITED
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy
Location
Unlock all 445 leads
Showing 50 of 445 — +395 more with verified decision-maker contacts, live data, and CRM sync.
How Manchester pharmaceuticals companies work and how to sell to them
What they do
Manchester pharmaceuticals firms usually earn revenue through regulated medicines supply, not one-off product sales alone. Common models include per-pack margins on distribution, batch-based manufacturing fees, formulation or analytical service fees, licensing income, pharmacovigilance retainers and project payments tied to regulatory or market-access milestones. Product shape varies from finished medicines and specialist formulations to import, assembly, quality release and wholesale logistics. Engagements tend to be operationally material because a failed supplier can delay treatment pathways, block product release or create inspection exposure. Pricing is therefore often linked to volume, batch complexity, storage requirements, release responsibility and the level of regulatory accountability the supplier carries.
Who they sell to
Typical buyers are institutional rather than consumer-facing: public healthcare procurement teams, hospital and community pharmacy channels, wholesalers, clinical operations groups, contract manufacturing partners, private healthcare operators and overseas distributors. Decision-makers tend to sit across quality, regulatory affairs, procurement, supply chain, medical affairs and finance, with technical sign-off often carrying as much weight as price. Smaller contracts may begin as qualification work, sample supply or project services, while larger relationships usually require audits, licence checks, quality agreements and supply continuity evidence before recurring orders. Routes to market are mixed, including direct commercial outreach, tendering, distributor partnerships and referrals from clinical or manufacturing networks.
What they buy
Most pharmaceuticals firms tend to spend on systems and services that protect licence status, product quality and supply reliability. Relevant categories include quality management software, document control, batch record tools, laboratory information systems, inventory and warehouse management, temperature monitoring, pharmacovigilance case handling, regulatory information management and audit workflow. They also buy specialist legal, accountancy, tax, insurance, validation, calibration, cleaning, packaging, recruitment and regulatory consultancy services. Infrastructure spend can include controlled storage, cold-chain logistics, cleanroom support, laboratory equipment, cyber security and finance operations. Sellers should expect more scrutiny where a purchase touches good manufacturing practice, good distribution practice, patient safety or market authorisation obligations.
Why and how to sell to them
Pharmaceuticals buyers tend to evaluate suppliers when operational risk becomes visible: a new licence application, an MHRA inspection window, a warehouse move, a product launch, an export route, a batch-release bottleneck, a quality-system gap or a leadership change in regulatory, quality or supply chain. Growth from project work into repeat supply is another common trigger, because informal processes start to strain under audit and documentation demands. Outbound messages usually land better when they address a named operational problem: cleaner audit trails, faster deviation handling, steadier stock visibility, simpler supplier qualification or lower inspection exposure. Generic productivity claims are less persuasive than evidence that the seller understands controlled, documented medicines workflows.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Manchester
Related directories
Frequently asked questions
How many pharmaceuticals companies are there in the Manchester?↓
What counts as a pharmaceuticals company in this list?↓
Which are the largest pharmaceuticals companies in the Manchester?↓
What do pharmaceuticals companies in the Manchester actually do?↓
How does Manchester pharmaceuticals compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharmaceuticals companies in the Manchester?↓
Are these mostly new or established pharmaceuticals companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 445 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.